Polymorphic form of piroxicam influences the performance of amorphous material prepared by ball-milling

International Journal of Pharmaceutics

Volumn 429, Issue 1-2, 2012, Pages 69-77

  Naelapää, Kaisa ^a   Boetker, Johan Peter ^a   Veski, Peep ^b   Rantanen, Jukka ^a   Rades, Thomas ^c   Kogermann, Karin ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF TARTU   (Estonia)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Amorphous; Pair wise distribution function (PDF); Physical stability; Piroxicam polymorphs; Principal component analysis (PCA); Raman spectroscopy; Solid state transformations; Thermal behavior; Variable temperature X ray powder diffractometry (VT XRPD)

Indexed keywords

PIROXICAM;

ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RAMAN SPECTROMETRY; SAMPLE; STORAGE; TEMPERATURE STRESS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALORIMETRY, DIFFERENTIAL SCANNING; CRYSTALLIZATION; DRUG COMPOUNDING; DRUG STABILITY; DRUG STORAGE; MULTIVARIATE ANALYSIS; PIROXICAM; SOLUBILITY; SPECTRUM ANALYSIS, RAMAN; TEMPERATURE; X-RAY DIFFRACTION;

EID: 84859597163     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.03.008     Document Type: Article

References (39)

1. F.H. Allen The Cambridge Structural Database: a quarter of a million crystal structures and rising Acta Crystallogr. B 58 2002 380 388 (Pubitemid 135702674)
2. Y. Aso, S. Yoshioka, and S. Kojima Molecular mobility-based estimation of the crystallization rates of amorphous nifedipine and phenobarbital in poly(vinylpyrrolidone) solid dispersions J. Pharm. Sci. 93 2003 384 391 (Pubitemid 38180444)
3. P. Augustijns, and M.E. Brewster Supersaturating drug delivery systems: fast is not necessarily good enough J. Pharm. Sci. 101 2012 7 9
4. S. Bates, G. Zografi, D. Engers, K. Morris, K. Crowley, and A. Newman Analysis of amorphous and nanocrystalline solids from their X-ray diffraction patterns Pharm. Res. 23 2006 2333 2349 (Pubitemid 44515011)
5. S.J.L. Billinge Characterisation of amorphous and nanocrystalline molecular materials by total scattering CrystEngComm 12 2010 1366 1368
6. 2O Acta Crystallogr. C 40 1984 989 990
7. J.P. Boetker, P. Karmwar, C.J. Strachan, C. Cornett, F. Tian, Z. Zujovic, J. Rantanen, and T. Rades Assessment of crystalline disorder in cryo-milled samples of indomethacin using atomic pair-wise distribution functions Int. J. Pharm. 417 2011 112 119
8. J. Brouwers, M.E. Brewster, and P. Augustijns Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability? J. Pharm. Sci. 98 2009 2549 2572
9. D.Q.M. Craig, M. Barsnes, P.G. Royall, and V.L. Kett An evaluation of the use of modulated temperature DSC as a means of assessing the relaxation behaviour of amorphous lactose Pharm. Res. 17 2000 696 700 (Pubitemid 30670635)
10. K.J. Crowley, and G. Zografi Cryogenic grinding of indomethacin polymorphs and solvates: assessment of amorphous phase formation and amorphous phase physical stability J. Pharm. Sci. 91 2002 492 507 (Pubitemid 34139812)
11. R.E. Dinnebier, and S.J.L. Billinge Powder Diffraction: Theory and Practice 2008 Royal Society of Chemistry Cambridge
12. T. Egami, and S.J.L. Billinge Underneath the Bragg peaks: structural analysis of complex materials R.W. Cahn, Pergamon Materials Series 2003 Pergamon Press, Elsevier Ltd. Oxford
13. K.A. Graeser, J.E. Patterson, J.A. Zeitler, K.C. Gordon, and T. Rades Correlating thermodynamic and kinetic parameters with amorphous stability Eur. J. Pharm. Sci. 37 2009 492 498
14. L.R. Hilden, and K.R. Morris Prediction of the relaxation behavior of amorphous pharmaceutical compounds. I: master curves concept and practice J. Pharm. Sci. 92 2003 1464 1472 (Pubitemid 36798073)
15. ICH ICH Q8(R2) Guidance for Industry. Pharmaceutical Development, International Conference on Harmonization EMEA/CHMP/ICH/167068/042006 2009
16. S. Ingkatawornwong, N. Kaewnopparat, and V. Tantishaiyakul Studies on aging piroxicam-polyvinylpyrrolidone solid dispersions Pharmazie 56 2001 227 230 (Pubitemid 32209949)
17. J. Jinno, D.M. Oh, J.R. Crison, and G.L. Amidon Dissolution of ionizable water-insoluble drugs: the combined effect of pH and surfactant J. Pharm. Sci. 89 2000 268 274 (Pubitemid 30120807)
18. A.C. Jørgensen, I. Miroshnyk, M. Karjalainen, K. Jouppila, S. Siiriä, O. Antikainen, and J. Rantanen Multivariate data analysis as a fast tool in evaluation of solid state phenomena J. Pharm. Sci. 95 2006 906 916
19. P. Karmwar, J. Boetker, K. Graeser, C.J. Strachan, J. Rantanen, and T. Rades Investigations on the effect of different cooling rates on the stability of amorphous indomethacin Eur. J. Pharm. Sci. 44 2011 341 350
20. P. Karmwar, K. Graeser, K.C. Gordon, C.J. Strachan, and T. Rades Investigation of properties and recrystallisation behaviour of amorphous indomethacin samples prepared by different methods Int. J. Pharm. 417 2011 94 100
21. K. Kogermann, J. Aaltonen, C.J. Strachan, K. Pöllänen, J. Heinämäki, J. Yliruusi, and J. Rantanen Establishing quantitative in-line analysis of multiple solid-state transformations during dehydration J. Pharm. Sci. 97 2008 4983 4999
22. K. Kogermann, J. Aaltonen, C.J. Strachan, K. Pöllänen, P. Veski, J. Heinämäki, J. Yliruusi, and J. Rantanen Qualitative in situ analysis of multiple solid-state forms using spectroscopy and partial least squares discriminant modeling J. Pharm. Sci. 96 2007 1802 1820 (Pubitemid 47122957)
23. K. Kogermann, J.A. Zeitler, J. Rantanen, T. Rades, P.F. Taday, M. Pepper, J. Heinämäki, and C.J. Strachan Investigating dehydration from compacts using terahertz pulsed Raman and near-infrared spectroscopy Appl. Spectrosc. 61 2007 1265 1274 (Pubitemid 351189512)
24. K. Kogermann, P. Veski, J. Rantanen, and K. Naelapää X-ray powder diffractometry in combination with principal component analysis - a tool for monitoring solid state changes Eur. J. Pharm. Sci. 43 2011 278 289
25. B. Kojic-Prodic, and Z. Ruzic-Toros Structure of piroxicam Acta Crystallogr. B 38 1982 2948
26. K.R. Morris, U.J. Griesser, C.J. Eckhardt, and J.G. Stowell Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes Adv. Drug Deliv. Rev. 48 2001 91 114 (Pubitemid 32452293)
27. V. Petkov Simultaneity, conventionality and existence Br. J. Philos. Sci. 40 1989 69 76
28. G. Reck, G. Dietz, G. Laban, W. Günther, G. Bannier, and E. Höhne X-ray studies on piroxicam modifications Pharmazie 43 1988 477 481
29. M. Savolainen, A. Heinz, C.J. Strachan, K.C. Gordon, J. Yliruusi, T. Rades, and N. Sandler Screening for differences in the amorphous state of indomethacin using multivariate visualization Eur. J. Pharm. Sci. 30 2007 113 123 (Pubitemid 46149278)
30. M. Savolainen, K. Kogermann, A. Heinz, J. Aaltonen, L. Peltonen, C. Strachan, and J. Yliruusi Better understanding of dissolution behaviour of amorphous drugs by in situ solid-state analysis using Raman spectroscopy Eur. J. Pharm. Biopharm. 71 2009 71 79
31. T.P. Shakhtshneider, F. Danéde, F. Capet, J.F. Willart, M. Descamps, S.A. Myz, E.V. Boldyreva, and V.V. Boldyrev Grinding of drugs with pharmaceutical excipients at cryogenic temperatures. Part I: cryogenic grinding of piroxicam-polyvinylpyrrolidone mixtures J. Therm. Anal. Calorim. 89 2007 699 707 (Pubitemid 47351761)
32. A.R. Sheth, S. Bates, F.X. Muller, and D.J.W. Grant Local structure in amorphous phases of piroxicam from powder X-ray diffractometry Cryst. Growth Des. 5 2004 571 578
33. A.R. Sheth, S. Bates, F.X. Muller, and D.J.W. Grant Polymorphism in piroxicam Cryst. Growth Des. 4 2004 1091 1098 (Pubitemid 39531985)
34. Y. Shibata, M. Fujii, M. Kokudai, S. Noda, H. Okada, M. Kondoh, and Y. Watanabe Effect of characteristics of compounds on maintainance of an amorphous state in solid dispersion with crospovidone J. Pharm. Sci. 96 2006 1537 1547 (Pubitemid 46953769)
35. R. Surana, A. Pyne, and R. Suryanarayanan Effect of aging on the physical properties of amorphous trehalose Pharm. Res. 21 2004 867 874 (Pubitemid 39011313)
36. R. Surana, A. Pyne, and R. Suryanarayanan Effect of preparation method on physical properties of amorphous trehalose Pharm. Res. 21 2004 1167 1176 (Pubitemid 38960768)
37. F. Vrečer, M. Vrbinc, and A. Meden Characterization of piroxicam crystal modifications Int. J. Pharm. 256 2003 3 15 (Pubitemid 36412135)
38. K. Winkel, W. Hage, T. Loerting, S.L. Price, and E. Mayer Carbonic acid: from polyamorphism to polymorphism J. Am. Chem. Soc. 129 2007 13863 13871 (Pubitemid 350106076)
39. E. Yonemochi, T. Hoshino, Y. Yoshihashi, and K. Terada Evaluation of the physical stability and local crystallization of amorphous terfenadine using XRD-DSC and micro-TA Thermochim. Acta 432 2005 70 75 (Pubitemid 41536852)